Advertisement

Heparin Premixed Bags

[08 March 2016]

Products Affected - Description

Heparin Sodium solution for injection, Hospira
12,500 unit/250 mL in 5% Dextrose, premixed bag, 24 count (NDC 00409-7794-62)
20,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count (NDC 00409-7760-03)
25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count (NDC 00409-7793-62)
25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count (NDC 00409-7761-03)

Reason for the Shortage

  • Baxter and BBraun have product available.
  • Hospira states the reason for the shortage is manufacturing delays.

Available Products

Heparin Sodium solution for injection, BBraun
1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 24 count (NDC 00264-9872-10)
20,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count (NDC 00264-9567-10)
25,000 unit/250 mL in 5% Dextrose, premixed bag, 24 count (NDC 00264-9587-20)
25,000 unit/500 mL in 5% Dextrose, premixed bag, 24 count (NDC 00264-9577-10)
 
Heparin Sodium solution for injection, Baxter
1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 18 count (NDC 00338-0431-03)
2,000 unit/1000 mL in 5% Dextrose, premixed bag, 12 count (NDC 00338-0433-04)

Heparin Sodium solution for injection, Hospira
1,000 unit/500 mL in 0.9% Sodium Chloride, premixed bag, 18 count (NDC 00409-7620-03)
2,000 unit/1000 mL in 0.9% Sodium Chloride, premixed bag, 12 count, (NDC 00409-7620-59)
12,500 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count (NDC 00409-7651-62)
25,000 unit/250 mL in 0.45% Sodium Chloride, premixed bag, 24 count,(NDC 00409-7650-62)
25,000 unit/500 mL in 0.45% Sodium Chloride, premixed bag, 24 count (NDC 00409-7651-03)

Estimated Resupply Dates

  • Hospira has heparin sodium 12,500 unit/250 mL in 5% dextrose and 25,000 unit/250 mL in 5% dextrose premixed bags on long-term back order and the company cannot estimate a release date. Heparin sodium 20,000 unit/250 mL in 5% dextrose and heparin sodium 25,000 unit/500 mL in 5% dextrose premixed bags are on long-term back order and the company cannot estimate a release date.
  • All other marketed presentations are available.

Related Shortages

Updated

March 8, January 14, 2016; December 9, September 21, August 17, June 29, May 19, March 27, February 3, January 14, 2015; December 7, October 29, September 10, August 27, July 30, 17 and 1, June 17, May 30, 19 and 7, April 24, March 28, February 28, January 21, 2014; December 19, November 27, October 8, September 24, August 19, June 28, April 8, March 19 and 12, February 28 and 6, January 11, 2013; November 19, October 16, September 7, August 13, July 11, June 25, May 30, 18 and 2, February 29, January 27, 2012; November 22, October 12, September 27, May 31, January 26, 2011; December 2, November 15, October 18, September 29, June 1, May 28, February 10, January 5, 2010; December 1, October 20, September 18, July 16, May 20, January 5, 2009; November 17, October 1, August 12, July 10, June 2, May 12, April 30, March 24, February 29, 2008, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing